Search - tctmd.com

Displaying 641 - 660 of 754

Sort: Relevancy | Date

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

Meta-analyses Shed Light on the Impact of DAPT Duration

Caitlin E. Cox

April 03, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

January 29, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Features

Despite New Findings, Optimal DAPT Duration Still Up in the Air

Todd Neale

December 10, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

Presentation TCT 2014

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Antonio Colombo

September 15, 2014

Presentation TCT 2014

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Nikolaus Sarafoff

September 15, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

Advertisement

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Meta-analyses Shed Light on the Impact of DAPT Duration

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

Poor Responders to Statins at Risk for CAD Progression

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Long-term Ticagrelor Therapy Cost-Effective in US Patients

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Despite New Findings, Optimal DAPT Duration Still Up in the Air

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content